🇺🇸 FDA

Drug profile · INN

prochlorperazine

APO-PROCHLORPERAZINE

approved
US status
approved
Patents linked
4
News articles
0

Quick answer

prochlorperazine (APO-PROCHLORPERAZINE) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd. Route of administration: rectal. Current US regulatory status: approved.

Key facts

INN prochlorperazine
Brand APO-PROCHLORPERAZINE
Route RECTAL
Formulation SUPPOSITORY
Originator Alphapharm Pty Ltd

Related patents

Search patents →

  1. US 10369208

    Methods for the induction of immune responses in a subject compromising administering virus-like particles (VLPS) prepared from Chikungunya virus structural proteins

    Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9044419

    Vaccine compositions compromising βs-crystallin for inducing immune responses against components of drusen

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8263091

    Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides

    Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 6444872

    Large animal model of invasive pulmonary aspergillosis in an immunocompromised host

    Expires Mon Aug 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is prochlorperazine?

prochlorperazine (APO-PROCHLORPERAZINE) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd. Route of administration: rectal. Current US regulatory status: approved.

What is the brand name for prochlorperazine?

APO-PROCHLORPERAZINE is a marketed brand name for prochlorperazine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of prochlorperazine?

prochlorperazine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.